|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's Range||129.79 - 138.66|
|52 Week Range||15.12 - 150.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 04, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||130.41|
Shares of Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO), two telehealth companies that recently agreed to merge, rose sharply on Tuesday. The stocks' move higher was likely fueled by a combination of an overall bullish trading day for tech stocks and an analyst's decision to initiate coverage of Teladoc stock with a buy rating. D.A. Davidson analyst Hannah Baade initiated coverage of Teladoc with a buy rating and a $250 12-month price target.
Here's why Ontrak (NASDAQ: OTRK), Nano-X Imaging (NASDAQ: NNOX), and Zymeworks (NYSE: ZYME) are all strong candidates for stratospheric outperformance by 2025. Will Ontrak overtake Livongo Health? Ontrak is competing with market leader Livongo Health (NASDAQ: LVGO) in a new virtual niche that marries the internet with healthcare knowledge.
This past Wednesday, Sept. 16, cloud data giant Snowflake (NYSE: SNOW) made its debut. Early indications had the company pricing its IPO at a range of $75 to $80 a share, but Snowflake officially set its list price at $120. When the closing bell rang on the company's first day of trading, Snowflake's shares had risen nearly $134, or 112%, from its IPO price to close at just shy of $254.